Press Release: CPSI Biotech : Novel FrostBite Cryoablation Technology for the Treatment of Pancreatic Cancer Wins NIH SBIR Phase II Award
CPSI Biotech receives a multi-year grant from the National Cancer Institute to develop a next generation minimally invasive endoscopic ultrasound compatible cryoablation probe to treat cancer
Read full article »
CPSI Biotech designs and develops cryo-medical devices for cancer and cardiovascular disease treatments.
Read more